Novartis Focalin Price Similar To Ritalin; ADHD Drug Clears FDA Nov. 13
Executive Summary
Novartis' Focalin will be priced similarly to its parent compound Ritalin, the company said following the Nov. 13 approval of the attention deficit hyperactivity disorder drug